BIOMAT Database Logo BIOMAT Database Logo

In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. 1991

M Venditti, and B Posteraro, and G Morace, and P Martino
Patologia Medica II, Istituto di Clinica Medica VI, Università La Sapienza, Roma, Italy.

Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003904 Mitosporic Fungi A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group. Deuteromycetes,Deuteromycota,Fungi imperfecti,Fungi, Mitosporic,Hyphomycetes,Deuteromycete,Deuteromycotas,Fungi imperfectus,Fungus, Mitosporic,Hyphomycete,Mitosporic Fungus,imperfectus, Fungi
D005848 Geotrichum A mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces. Geotrichums
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D014250 Trichosporon A mitosporic fungal genus causing opportunistic infections, endocarditis, fungemia, a hypersensitivity pneumonitis (see TRICHOSPORONOSIS) and white PIEDRA. Trichosporons
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858

Related Publications

M Venditti, and B Posteraro, and G Morace, and P Martino
Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient.
September 1991, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M Venditti, and B Posteraro, and G Morace, and P Martino
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
April 2009, Mikrobiyoloji bulteni,
M Venditti, and B Posteraro, and G Morace, and P Martino
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
November 2003, Enfermedades infecciosas y microbiologia clinica,
M Venditti, and B Posteraro, and G Morace, and P Martino
Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.
March 1996, Journal of clinical microbiology,
M Venditti, and B Posteraro, and G Morace, and P Martino
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
August 2004, Antimicrobial agents and chemotherapy,
M Venditti, and B Posteraro, and G Morace, and P Martino
[Antifungal activity of fluconazole in vitro].
January 1995, Medycyna doswiadczalna i mikrobiologia,
M Venditti, and B Posteraro, and G Morace, and P Martino
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.
May 2021, Journal of fungi (Basel, Switzerland),
M Venditti, and B Posteraro, and G Morace, and P Martino
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
April 2023, Mycopathologia,
M Venditti, and B Posteraro, and G Morace, and P Martino
[Blastoschizomyces capitatus fungemia in a neutropenic patient].
January 2000, Enfermedades infecciosas y microbiologia clinica,
M Venditti, and B Posteraro, and G Morace, and P Martino
Blastoschizomyces capitatus pneumonia in an immunocompetent male.
July 2004, Southern medical journal,
Copied contents to your clipboard!